Crohn's Disease News and Research

Latest Crohn's Disease News and Research

People who consume sugar for extended periods have increased risk of autoimmune disease

People who consume sugar and other carbohydrates in excess over a long period of time have an increased risk of developing an autoimmune disease.

23 Mar 2022

New insight into how gut bacteria work to counter intestinal inflammation

Bile acids made by the liver have long been known for their critical role in helping to absorb the food we ingest.

16 Mar 2022

New computational biology method deciphers gut microbiome ‘chatter’ to fight IBD

Around 500,000 people in the UK live with Inflammatory Bowel Disease (IBD), a life-long, chronic condition characterized by sporadic bouts of gut inflammation causing debilitating symptoms.

14 Mar 2022

Intensive treatment for patients with Crohn's disease found to be safe

Intensive treatment for patients with Crohn's disease showed no safety differences compared to the current standard of care, according to a trial published in the journal Gastroenterology.

1 Mar 2022

Potential new diagnostic marker for ulcerative colitis discovered

An international research collaboration has discovered a potential new diagnostic marker for ulcerative colitis in a trans-ethnic analysis of Japanese and white patients.

10 Feb 2022

Research lays the groundwork to better understand and treat Crohn's disease

A paper published this week in Immunity, a leading research journal highlighting discoveries in immunology by Cell Press, lays the groundwork to better understand and treat Crohn's disease, a type of Inflammatory Bowel Disease (IBD).

9 Feb 2022

Growth factor can powerfully counter the harmful effects of inflammatory bowel disease

A growth factor protein produced by rare immune cells in the intestine can protect against the effects of inflammatory bowel disease (IBD), according to a new discovery from Weill Cornell Medicine researchers.

31 Jan 2022

Hospitalization risk high for IBD patients with incomplete COVID-19 vaccinations

The Crohn's & Colitis Foundation and the American Gastroenterological Association (AGA) are bringing together the inflammatory bowel disease (IBD) care community for the fifth annual Crohn's & Colitis Congress®, taking place virtually Jan. 20 through 22, 2022.

21 Jan 2022

Research may lead to new treatment options for Crohn's disease patients

Results of a new study by researchers at Case Western Reserve University represent a step toward improving our understanding of Crohn's disease and the factors that cause its intestinal inflammation.

10 Jan 2022

Medical marijuana users brace for shortages as Montana’s recreational market opens

More than a year after voters approved legalizing marijuana for recreational use in Montana, anyone older than 21 can now enter a dispensary and buy cannabis. That has medical marijuana user Joylynn Mane Wright worried.

5 Jan 2022

People with IBD accumulate more fecal microplastics, study finds

Microplastics -; tiny pieces of plastic less than 5 mm in length –– are everywhere, from bottled water to food to air. According to recent estimates, people consume tens of thousands of these particles each year, with unknown health consequences.

22 Dec 2021

A new approach for drugs to be more effective against inflammatory bowel disease

Biomedical scientists at the University of California, Riverside, propose a way for drugs to be more effective against inflammatory bowel disease, or IBD, in which the intestine undergoes inflammation.

18 Dec 2021

Researchers mapping the extent of IBD in the UK are seeking people's help

Scientists mapping the extent of Inflammatory Bowel Disease (IBD) in the UK are asking the public to help. Crohn's Disease and Ulcerative Colitis are the two main forms of IBD and affect more than 500,000people in theUK.

1 Dec 2021

People taking immunosuppressant produce weaker, shorter-lived antibodies after COVID-19 vaccination

People who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors -; a class of immunosuppressants used to treat rheumatoid arthritis and other autoimmune conditions -; generated less powerful and shorter-lived antibodies against the virus that causes COVID-19 than healthy people and those on other kinds of immunosuppressants, according to a study by researchers at Washington University School of Medicine in St. Louis.

21 Nov 2021

Crohn's Disease News and Research

Latest Crohn's Disease News and Research

People who consume sugar for extended periods have increased risk of autoimmune disease

New insight into how gut bacteria work to counter intestinal inflammation

New computational biology method deciphers gut microbiome ‘chatter’ to fight IBD

Intensive treatment for patients with Crohn's disease found to be safe

Potential new diagnostic marker for ulcerative colitis discovered

Research lays the groundwork to better understand and treat Crohn's disease

Growth factor can powerfully counter the harmful effects of inflammatory bowel disease

Hospitalization risk high for IBD patients with incomplete COVID-19 vaccinations

Research may lead to new treatment options for Crohn's disease patients

Medical marijuana users brace for shortages as Montana’s recreational market opens

People with IBD accumulate more fecal microplastics, study finds

A new approach for drugs to be more effective against inflammatory bowel disease

Researchers mapping the extent of IBD in the UK are seeking people's help

People taking immunosuppressant produce weaker, shorter-lived antibodies after COVID-19 vaccination

Study identifies possible link between psychological stress and Crohn's disease flare-ups

Research shows how inflammatory reactions can be resolved by changes to metabolism of macrophages

Study identifies serotonin as a possible trigger of flare-ups in Crohn's disease

IBD patients produce a strong antibody response to COVID-19 vaccination, finds study

Novel drug improves management of ulcerative colitis

Can targeting autophagy become a new approach to COVID-19 treatment?

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Crohn's Disease News and Research

Latest Crohn's Disease News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in